A Combined In Vitro/In Silico Approach to Identifying Off-Target Receptor Toxicity
Joseph Leedale1, Kieran J Sharkey1, Helen E Colley2
1EPSRC Liverpool Centre for Mathematics in Healthcare, Department of Mathematical Sciences, University of Liverpool, Liverpool L69 7ZL, UK.
Abstract:
Many xenobiotics can bind to off-target receptors and cause toxicity via the dysregulation of downstream transcription factors. Identification of subsequent off-target toxicity in these chemicals has often required extensive chemical testing in animal models. An alternative, integrated in vitro/in silico approach for predicting toxic off-target functional responses is presented to refine in vitro receptor identification and reduce the burden on in vivo testing. As part of the methodology, mathematical modeling is used to mechanistically describe processes that regulate transcriptional activity following receptor-ligand binding informed by transcription factor signaling assays. Critical reactions in the signaling cascade are identified to highlight potential perturbation points in the biochemical network that can guide and optimize additional in vitro testing. A physiologically based pharmacokinetic model provides information on the timing and localization of different levels of receptor activation informing whole-body toxic potential resulting from off-target binding.
Insights
This study presents an integrated in vitro/in silico method to predict chemical toxicity by analyzing off-target receptor binding and transcription factor dysregulation, reducing animal testing.
Area of Science:
- Toxicology and computational chemistry
- Pharmacology and molecular biology
Background:
- Xenobiotics can cause toxicity by binding to unintended receptors, disrupting transcription factors.
- Current methods for identifying chemical toxicity often rely on extensive animal testing.
Purpose of the Study:
- To develop an integrated in vitro/in silico approach for predicting toxicological responses from off-target receptor binding.
- To refine in vitro receptor identification and minimize the need for in vivo studies.
Main Methods:
- Utilizing mathematical modeling to mechanistically describe transcriptional activity post-receptor-ligand binding.
- Employing transcription factor signaling assays to inform the mathematical models.
- Identifying critical reactions within signaling cascades to pinpoint potential intervention points.
- Integrating physiologically based pharmacokinetic (PBPK) modeling to predict whole-body toxic potential.
Main Results:
- The developed methodology successfully models the mechanistic links between receptor-ligand binding and downstream transcriptional changes.
- Identification of key regulatory points in signaling pathways allows for optimized in vitro testing strategies.
- PBPK modeling provides crucial temporal and spatial information on receptor activation, enhancing toxicity predictions.
Conclusions:
- The integrated in vitro/in silico approach offers a viable alternative to traditional animal testing for predicting chemical toxicity.
- This strategy refines the understanding of off-target effects and improves the efficiency of toxicological assessments.
- The methodology aids in identifying potential hazards early in chemical development, reducing risks and resource utilization.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Internal Receptors
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Receptor-mediated Endocytosis
In-vitro Mutagenesis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors
